Literature DB >> 12433988

Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex.

Janice D Pata1, Bradford R King, Thomas A Steitz.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) initiates DNA synthesis from the 3' end of human tRNA(Lys3). We have used cis-acting hammerhead ribozymes to produce homogeneous-length transcribed tRNA(Lys3) and have developed conditions for purifying highly structured RNAs on a modified tube-gel apparatus. Titration experiments show that this RNA can assemble into an initiation complex that contains equimolar amounts of HIV-1 RT, transcribed tRNA(Lys3), and chemically synthesized template RNA. We have purified this complex using gel-filtration chromatography and have found that it is homogeneous with respect to molecular weight, demonstrating that the initiation complex forms a single discrete species at micromolar concentrations. When this initiation complex is supplied with deoxynucleotides, essentially all of the tRNA is used as a primer by HIV-1 RT and is fully extended to the 5' end of the template. Thus, in vitro transcribed tRNA can be used efficiently as a primer by HIV-1 RT. We have also obtained crystals of the HIV-1 initiation complex that require the precisely defined ends of this in vitro transcribed tRNA(Lys3) to grow.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433988      PMCID: PMC137168          DOI: 10.1093/nar/gkf620

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  Crystallization of RNA-protein complexes. I. Methods for the large-scale preparation of RNA suitable for crystallographic studies.

Authors:  S R Price; N Ito; C Oubridge; J M Avis; K Nagai
Journal:  J Mol Biol       Date:  1995-06-02       Impact factor: 5.469

2.  Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  S F Le Grice; C E Cameron; S J Benkovic
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).

Authors:  C Barat; S F Le Grice; J L Darlix
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

4.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Reverse transcriptase of human immunodeficiency virus can use either human tRNA(3Lys) or Escherichia coli tRNA(2Gln) as a primer in an in vitro primer-utilization assay.

Authors:  L A Kohlstaedt; T A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.

Authors:  H Zhang; G Dornadula; Y Wu; D Havlir; D D Richman; R J Pomerantz
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

8.  Human immunodeficiency virus-1 reverse transcriptase heterodimer stability.

Authors:  J Lebowitz; S Kar; E Braswell; S McPherson; D L Richard
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

9.  Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; J Ding; E Arnold; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Site-specific crosslinking of 4-thiouridine-modified human tRNA(3Lys) to reverse transcriptase from human immunodeficiency virus type I.

Authors:  Y Mishima; J A Steitz
Journal:  EMBO J       Date:  1995-06-01       Impact factor: 11.598

View more
  2 in total

1.  Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors.

Authors:  Janice D Pata; William G Stirtan; Steven W Goldstein; Thomas A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

2.  Synthetic tRNALys,3 as the replication primer for the HIV-1HXB2 and HIV-1Mal genomes.

Authors:  Jennifer T Miller; Anastasia Khvorova; Stephen A Scaringe; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-09-01       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.